Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix-Martin Werner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Epilepsy & Behavior : E&B|March 31, 2015
Classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: How to improve the antiepileptic effect?Felix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|February 16, 2021
Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic TreatmentFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|March 21, 2019
Neural Networks in Generalized Epilepsy and Novel Antiepileptic DrugsFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|October 8, 2021
Importance of Risk Genes in Neurological and Psychiatric Diseases and the Influence of the Function of These Risk Genes for Choosing the Appropriate PharmacotherapyFelix-Martin Werner, Rafael Coveñas
Expert Opinion on Drug Safety|July 1, 2014
Safety of antipsychotic drugs: focus on therapeutic and adverse effectsFelix-Martin Werner, Rafael Coveñas
Recent Patents on Anti-Infective Drug Discovery|October 27, 2015
Methicillin-Resistant Staphylococcus aureus: Treatment with Cultures of Non Drug-Resistant Staphylococcus epidermidisFelix-Martin Werner, Rafael Covenas
Recent Patents on Anti-Infective Drug Discovery|August 28, 2015
Methicillin-resistant Staphylococcus aureus: treatment with cultures of not drug-resistant Staphylocuccus epidermidisFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|May 23, 2023
Improved radioimmunodetection of carcinomas with a re-injection of monoclonal antibodies after formation of anti-mouse antibodiesFelix-Martin Werner, Rafael Covenas
Biomedicines|November 27, 2025
Closing Editorial for the Special Issue: "Advanced Treatment of Schizophrenia"Felix-Martin Werner, Rafael Coveñas
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Epilepsy & Behavior : E&B|March 31, 2015
Classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: How to improve the antiepileptic effect?Felix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|February 16, 2021
Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic TreatmentFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|March 21, 2019
Neural Networks in Generalized Epilepsy and Novel Antiepileptic DrugsFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|October 8, 2021
Importance of Risk Genes in Neurological and Psychiatric Diseases and the Influence of the Function of These Risk Genes for Choosing the Appropriate PharmacotherapyFelix-Martin Werner, Rafael Coveñas
Expert Opinion on Drug Safety|July 1, 2014
Safety of antipsychotic drugs: focus on therapeutic and adverse effectsFelix-Martin Werner, Rafael Coveñas
Recent Patents on Anti-Infective Drug Discovery|October 27, 2015
Methicillin-Resistant Staphylococcus aureus: Treatment with Cultures of Non Drug-Resistant Staphylococcus epidermidisFelix-Martin Werner, Rafael Covenas
Recent Patents on Anti-Infective Drug Discovery|August 28, 2015
Methicillin-resistant Staphylococcus aureus: treatment with cultures of not drug-resistant Staphylocuccus epidermidisFelix-Martin Werner, Rafael Coveñas
Current Pharmaceutical Design|May 23, 2023
Improved radioimmunodetection of carcinomas with a re-injection of monoclonal antibodies after formation of anti-mouse antibodiesFelix-Martin Werner, Rafael Covenas
Biomedicines|November 27, 2025
Closing Editorial for the Special Issue: "Advanced Treatment of Schizophrenia"Felix-Martin Werner, Rafael Coveñas
Pageof 2